Rheumatology
Feature
UnitedHealthcare tried to deny coverage to a chronically ill patient. He fought back, exposing the insurer’s inner workings.
The college student’s medical bills were running nearly $2 million a year.
From the Journals
Prehospital COVID therapy effective in rheumatic disease patients
Patients with rheumatic disease and SARS-CoV-2 infection who received outpatient treatment fared better than similar patients who did not receive...
From the Journals
In families with gout, obesity and alcohol add to personal risk
Genetic makeup is the key driver for the increased risk of gout found in families with a history of the disease. This risk is increased in people...
From the Journals
Running does not cause lasting cartilage damage
A single bout of running causes only transient and small changes to the thickness and structure of healthy cartilage in the knee.
Latest News
First Humira biosimilar launches in U.S.
Amgen’s Amjevita will be offered at 5% and 55% below Humira’s list price, but patients may not benefit from the more significant discount.
Commentary
75 years: A look back on the fascinating history of methotrexate and folate antagonists
Dr. David Warmflash recounts how the meandering path of early research into chemotherapy for hematologic malignancies later led to methotrexate’s...
From the Journals
High HDL-C levels linked to increased fracture risk
High levels of high-density lipoprotein cholesterol are associated with a higher risk for fracture among older adults, a cohort study suggests.
From the Journals
VEXAS syndrome: More common, variable, and severe than expected
A large U.S. analysis found that this newly discovered genetic disease has a estimated prevalence of 1 in 4,269 in men older than 50.
From the Journals
‘Very doable’ low-dose workout enough to treat knee OA
Exercise helps patients with knee osteoarthritis, but more isn’t necessarily better, a new study found.
From the Journals
Best estimates made for hydroxychloroquine retinopathy risk
Hydroxychloroquine dosing and retinopathy risk have long been a concern with its use. A new, comprehensive study finds that retinopathy diagnosis...
From the Journals
Belimumab for pregnant women with lupus: B-cell concerns remain
The largest combined analysis of birth outcome data found no apparent increase in birth defects or pregnancy loss with belimumab, and a separate...